Home Cart Sign in  
Chemical Structure| 500794-88-7 Chemical Structure| 500794-88-7

Structure of TR antagonist 1
CAS No.: 500794-88-7

Chemical Structure| 500794-88-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TR antagonist 1 is a high-affinity thyroid hormone receptor (TR) antagonist with IC50s of 36 and 22 nM for TRα and TRβ, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TR antagonist 1

CAS No. :500794-88-7
Formula : C25H23Br2NO4
M.W : 561.26
SMILES Code : O=C(O)CCC1=CC(Br)=C(OC2=CC(/C=C/C3=CC=NC=C3)=C(O)C(C(C)C)=C2)C(Br)=C1
MDL No. :N/A

Safety of TR antagonist 1

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00129220 Bipolar Disorder Phase 3 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 470-1168 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Akita, Japan, 010-1654 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 283-0062 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 807-8555 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gunma, Japan, 370-2455 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 004-0841 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 663-8501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 236-0037 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kumamoto, Japan, 861-0002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagano, Japan, 384-8540 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 700-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okinawa, Japan, 904-2222 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 561-0803 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saga, Japan, 842-0192 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saitama, Japan, 343-0032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 160-0023 Less <<
NCT00129220 - Completed - -
NCT00599573 HIV Infections ... More >> Cocaine Dependence Less << Not Applicable Unknown December 2010 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Gabrielle Marzani-Nissen, MD    434-924-2241    grm2a@virginia.edu    Contact: Jennifer Crosby    434-243-0545    jac8tr@virginia.edu    Principal Investigator: Gabreille Marzani-Nissen, MD Less <<
NCT01972841 Urinary Bladder Overactive ... More >> Urinary Bladder Diseases\Urologic Diseases Overactive Bladder Urgency Incontinence Less << Phase 3 Completed - -
NCT02542657 Myeloma Phase 1 Phase 2 Recruiting July 2020 United States, California ... More >> University of California San Diego Recruiting La Jolla, California, United States, 92093-0960 Contact: Caitlin Costello    858-822-6387    ccostello@ucsd.edu    Principal Investigator: Caitlin Costello          University of California Irvine Recruiting Orange, California, United States, 92868 Contact: Elizabeth Brem, MD    714-456-5164    ebrem@uci.edu    University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Joseph M. Tuscano    916-734-3771    jtuscano@ucdavis.edu    Principal Investigator: Joseph M. Tuscano Less <<
NCT01682564 Hypertension ... More >>Congestive Heart Failure Less << Phase 4 Completed - Korea, Republic of ... More >> Inje university pusan hospital Busan, Busanjin-gu Gaegum-dong, Korea, Republic of, 614-735 Gyeongsang national university hospital Jinju, Chiram-dong, Korea, Republic of, 660-702 Daegu fatima hospital Daegu, Dong-gu Sinam-dong, Korea, Republic of, 701-724 Daedong hospital Busan, Dongnae-gu Myeongnyun-dong, Korea, Republic of, 607-711 Inje university haeundae paik hospital Busan, Haeundae-gu Heaundae-ro 875, Korea, Republic of, 612-030 Maryknoll medical center Busan, Jung-gu Daecheong-dong, Korea, Republic of, 600-730 Keimyung university dongsan medical center Daegu, Jung-gu Dongsan-dong, Korea, Republic of, 700-712 Kyungpook national university hospital Daegu, Jung-gu Samdeok-dong, Korea, Republic of, 700-721 Samsung changwon hospital Changwon, Masanhoiwon-gu Hapseong-dong 50, Korea, Republic of, 630-723 Yeungnam university medical center Daegu, Nam-gu Daemyeong-dong, Korea, Republic of, 705-717 Daegu catholic univ. medical center Daegu, Nam-gu Daemyung-dong, Korea, Republic of, 705-718 Kosin university gospel hospital Busan, Seo-gu Amnam-dong, Korea, Republic of, 602-702 Dong-A university medical center Busan, Seo-gu Dongdaesin-dong, Korea, Republic of, 602-715 Dongguk university gyeongju hospital Gyeongju, Seokjang-dong, Korea, Republic of, 780-350 Less <<
NCT02256540 Endothelial Dysfunction Not Applicable Active, not recruiting January 2019 United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT00774930 Carcinoid Syndrome Phase 3 Completed - -
NCT03713658 Schizophrenia Phase 4 Recruiting April 10, 2020 Rwanda ... More >> CARAES Ndera Neuro-Psychiatric Hospital Recruiting Kigali, Rwanda, 423 University Teaching Hospital of Kigali Not yet recruiting Kigali, Rwanda, 655 Ruhengeri Referral Hospital, Public Hospital Recruiting Musanze District, Rwanda, 57 Kibungo Referral Hospital Not yet recruiting Ngoma District, Rwanda, 10 Less <<
NCT03036800 Obesity Weigh... More >>t Loss Diabetes Mellitus Less << Phase 4 Recruiting January 2021 Ireland ... More >> St Vincent's University Hospital Recruiting Dublin, Ireland Contact: Carel Le Roux, Prof    0171 66 831    carel.leroux@ucd.ie    Principal Investigator: Carel LeRoux, Prof          Sub-Investigator: Donel O'Shea, Prof          United Kingdom NHS Greater Glasgow and Clyde West Glasgow Ambulatory Care Hospital Not yet recruiting Glasgow, United Kingdom Contact: Mike Lean, Prof    0141 201 8604    mike.lean@glasgow.ac.uk    University Hospitals of Leicester NHS Trust, Leicester General Hospital Recruiting Leicester, United Kingdom Contact: Melanie Davies, Prof    0116 258 6481    melanie.davies@uhl-tr.nhs.uk    Sub-Investigator: David Webb, Dr          University Hospital Aintree Recruiting Liverpool, United Kingdom Contact: John Wilding, Prof    0151 529 5899    J.P.H.Wilding@liverpool.ac.uk    Guy's and St Thomas' NHS Foundation Trust Recruiting London, United Kingdom Contact: Barbara McGowan, Dr    020 7188 1912    barbara.mcGowan@gstt.nhs.uk Less <<
NCT00774930 - Completed - -
NCT00821574 Hypertension, Dyslypidaemia Phase 4 Completed - -
NCT03687515 Chronic Rhinosinusitis With Po... More >>lyposis Less << Phase 3 Completed - -
NCT00343460 Nausea and Vomiting ... More >> Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 3 Completed - -
NCT03497975 Prurigo Nodularis Phase 2 Phase 3 Recruiting December 2020 United States, Maryland ... More >> Dermatology and Skin Cancer Specialists, LLC dba US Dermatology Partners Not yet recruiting Rockville, Maryland, United States, 20850 United States, New York Forest Hills Dermatology Group Recruiting Forest Hills, New York, United States, 11375 United States, North Carolina Wake Research Associates, LLC Recruiting Raleigh, North Carolina, United States, 27612 United States, Oklahoma Central Sooner Research Not yet recruiting Norman, Oklahoma, United States, 73071 United States, Pennsylvania Paddington Testing Company Recruiting Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00205777 - Completed - -
NCT00205777 Osteoporosis Phase 3 Completed - -
NCT02941926 Breast Cancer Phase 3 Active, not recruiting November 22, 2019 -
NCT00343460 - Completed - -
NCT02484859 Nasal Polyps Phase 4 Unknown April 2016 Turkey ... More >> Recep Tayyip Erdogan University Recruiting Rize, Eastern Blacksea, Turkey, 53100 Contact: Başar Erdivanlı, Asst    04642130491 ext 2128    basar.erdivanli@erdogan.edu.tr    Contact: Özlem Çelebi Erdivanlı, Asst    04642130491 ext 1392    ozlem.celebi@erdogan.edu.tr Less <<
NCT01972841 - Completed - -
NCT02122198 Cognitive Impairment ... More >> Executive Dysfunction Endothelial Dysfunction Cardiovascular Disease Less << Not Applicable Completed - United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 University of Colorado Boulder Intermountain Neuroimaging Consortium Boulder, Colorado, United States, 80309 Less <<
NCT02408445 Klinefelter Syndrome Phase 4 Active, not recruiting December 2018 United States, Colorado ... More >> Children's Hospital Colorado Aurora, Colorado, United States, 80045 Less <<
NCT01491035 Depressive Disorder ... More >> Anxiety Disorder Less << Phase 2 Completed - United States, District of Col... More >>umbia US003 Washington, District of Columbia, United States, 20010 United States, Kansas US004 Wichita, Kansas, United States, 67214 United States, Ohio US002 Cincinnatti, Ohio, United States, 45219 US001 Cleveland, Ohio, United States, 44106 Germany DE002 Berlin, Germany, 10249 DE001 Mainz, Germany, 55122 DE003 Ulm, Germany, 89075 Less <<
NCT03012763 Pharmacokinetics ... More >> Magnetic Resonance Imaging Administration, Oral Less << Phase 1 Completed - -
NCT01491035 - Completed - -
NCT00376272 Atrial Fibrillation Phase 3 Completed - -
NCT01635608 Gastrointestinal Motility Diso... More >>rder Less << Phase 1 Completed - Germany ... More >> Department of Clinical Pharmacology, Ernst-Moritz-Arndt-University Greifswald Greifswald, Meckleburg-Vorpommern, Germany, 17487 Less <<
NCT02597101 Type 2 Diabetes Mellitus ... More >> Insulin Resistance Less << Phase 2 Active, not recruiting May 2019 United States, Pennsylvania ... More >> Allegheny Health Network Pittsburgh, Pennsylvania, United States, 15224 Less <<
NCT03464383 Anxiety Depre... More >>ssion Epilepsy Less << Phase 4 Enrolling by invitation March 2019 United States, North Carolina ... More >> Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 Less <<
NCT01795547 Schizophrenia Phase 3 Completed - United States, California ... More >> US002 Los Angeles, California, United States, 90660 US006 San Diego, California, United States, 92102 Less <<
NCT01795547 - Completed - -
NCT02685644 - Unknown December 2018 -
NCT03229538 Congenital Heart Disease in Ch... More >>ildren Inflammatory Response Less << Phase 3 Recruiting February 28, 2021 United States, Colorado ... More >> University of Colorado, Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Moyers          Principal Investigator: James Jaggers          United States, Florida All Children's Research Institute Recruiting Saint Petersburg, Florida, United States, 33701 Contact: Research Coordinator          Principal Investigator: Jeff Jacobs, MD          United States, Illinois Ann & Robert Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611-2605 Contact: Research Coordinator          Principal Investigator: Eric Wald, MD          United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21205 Contact: Willhide          Principal Investigator: Marshall Jacobs          United States, New York Morgan Stanley Children's Hospital of New York Presbyterian Recruiting New York, New York, United States, 10032-3702 Contact: Research Coordinator          Principal Investigator: Brett Anderson, MD          United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Clinical Research Coordinator       mingfen.xu@duke.edu    Principal Investigator: Kevin Hill, M.D.          Sub-Investigator: Jennifer Li, M.D.          Sub-Investigator: Rachel Torok, M.D.          United States, Ohio Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229-3039 Contact: Research Coordinator          Principal Investigator: Alexis Benscoter, MD          United States, South Carolina Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Boehm          Principal Investigator: Eric Graham          United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Fountain          Sub-Investigator: Prince Kannankeril          Principal Investigator: Scott Baldwin          United States, Texas The University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390-9020 Contact: Research Coordinator          Principal Investigator: Ryan Butts, MD Less <<
NCT02709187 Healthy Phase 1 Completed - -
NCT02351934 Colorectal Disorders Phase 4 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT03522987 Anxiety Depre... More >>ssion Epilepsy Less << Phase 4 Withdrawn(Decided not to perfo... More >>rm the pilot phase) Less << May 2018 United States, North Carolina ... More >> Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00915473 - Completed - -
NCT02351934 - Completed - -
NCT01358357 Bipolar I Disorder Phase 3 Completed - -
NCT02723305 - Active, not recruiting December 2018 United States, Colorado ... More >> Children's Hospital Colorado Aurora, Colorado, United States, 80045 Less <<
NCT01358357 - Completed - -
NCT00177164 Bipolar I Disorder Phase 3 Completed - United States, Pennsylvania ... More >> Mayview State Hospital Bridgeville, Pennsylvania, United States, 15017-1599 Dubois Regional Medical Center Dubois, Pennsylvania, United States, 15801 Mon-Yough Community Services, Inc. McKeesport, Pennsylvania, United States, 15132 Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania, United States, 15213-2593 Less <<
NCT01015001 Schizophrenia ... More >> Auditory Hallucinations Less << Phase 3 Completed - Brazil ... More >> Hospital de Clinicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil Less <<
NCT01847001 Locally Advanced Malignant Neo... More >>plasm Breast Cancer Less << Phase 2 Active, not recruiting December 2018 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00915473 Migraine Headache Phase 4 Completed - United States, Arizona ... More >> Mayo Clinic Phoenix, Arizona, United States, 85054 Less <<
NCT02157974 Hepatic Steatosis ... More >> Polycystic Ovarian Syndrome Obesity Less << Phase 2 Phase 3 Recruiting December 2018 United States, Colorado ... More >> University of Colorado Anshutz Medical Campus/Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Yesenia Garcia    720-777-6984    yesenia.garciareyes@childrenscolorado.org Less <<
NCT03519386 Glaucoma, Open-Angle ... More >> Ocular Hypertension Less << Phase 3 Recruiting June 2023 United States, South Dakota ... More >> Vance Thompson Vision Recruiting Sioux Falls, South Dakota, United States, 57108 Contact: John P Berdahl, M.D.    605-361-3937    john.berdahl@vancethompsonvision.com Less <<
NCT01985334 COPD Phase 4 Completed - -
NCT02762643 Healthy Phase 1 Completed - -
NCT02165631 - Completed - United States, Colorado ... More >> University of Colorado Eye Center Aurora, Colorado, United States, 80045 Less <<
NCT00177164 - Completed - -
NCT02632877 Diabetic Foot Ulcer Phase 1 Phase 2 Completed - Mexico ... More >> Molecular Biology and Gene Therapy Institute Guadalajara, Jalisco, Mexico, 44340 Hospital Valentín Gómez Farías Zapopan, Jalisco, Mexico Less <<
NCT02389712 Bipolar Disorder Phase 4 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01306474 - Completed - China, Shaanxi ... More >> Department of Ophthalmology, Xijing Hosptial Xi'an, Shaanxi, China, 710032 Less <<
NCT02631954 Aspergillus Infections ... More >> Candida Infections Fungal Infections Less << Phase 1 Completed - Korea, Republic of ... More >> Inha University Hospital Jung-gu, Incheon, Korea, Republic of, 22332 Less <<
NCT00796302 Attention Deficit Disorder Wit... More >>h Hyperactivity Less << Phase 4 Completed - United States, New York ... More >> State University of New York Stony Brook Stony Brook, New York, United States, 11794 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Ohio State University Nisonger Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00796302 - Completed - -
NCT02647944 Obesity Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT02160990 Obesity Phase 4 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02160990 - Completed - -
NCT00816556 - Terminated(Funding) - -
NCT03523273 Obesity Phase 2 Recruiting December 2022 United States, Minnesota ... More >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Deb Eckert, RN          Principal Investigator: Michael Camilleri, MD Less <<
NCT01084499 Healthy Not Applicable Completed - -
NCT02647944 - Completed - -
NCT01086748 Schizophrenia Phase 2 Completed - -
NCT00262470 Tachycardia C... More >>hronic Orthostatic Intolerance Less << Phase 1 Phase 2 Active, not recruiting December 2021 United States, Tennessee ... More >> Vanderbilt University Autonomic Dysfunction Center Nashville, Tennessee, United States, 37232-2195 Less <<
NCT01651481 Rhinitis Phase 1 Completed - Korea, Republic of ... More >> Samsung medical center Seoul, Korea, Republic of Less <<
NCT00816556 Atrophic Vaginitis Phase 3 Terminated(Funding) - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00845026 Schizophrenia Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Escondido, California, United States, 92025 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Garden Grove, California, United States, 92845 United States, District of Columbia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Washington, District of Columbia, United States, 20016 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States, 60640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hoffman Estates, Illinois, United States, 60194 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46222 United States, Louisiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lake Charles, Louisiana, United States, 70601 United States, New Jersey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Willingboro, New Jersey, United States, 08046 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Amityville, New York, United States, 11701 United States, Oklahoma For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oklahoma City, Oklahoma, United States, 73103 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Desoto, Texas, United States, 75115 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jena, Germany, D-07740 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68159 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wiesbaden, Germany, D-65199 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guadalajara, Mexico, 44340 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico, 14420 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Monterrey, Mexico, 64290 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Khotkovo, Russian Federation, 127025 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lipetsk, Russian Federation, 399007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 123367 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nizhniy Novgorod, Russian Federation, 603155 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 192019 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Samara, Russian Federation, 443016 Less <<
NCT02633371 - Completed - -
NCT02737059 Constipation Drug Induced Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01529320 Allergic Contact Eczema Phase 1 Completed - Spain ... More >> Dermatology Service, Hospital del Mar, Parc de Salut Mar Barcelona, Spain, 08003 Less <<
NCT02633371 Hyperhidrosis Not Applicable Completed - United States, Colorado ... More >> Children's Hospital, Colorado Aurora, Colorado, United States, 80045 Less <<
NCT02373215 Uremic Pruritus Phase 1 Completed - -
NCT03010267 Healthy Phase 1 Completed - -
NCT02544321 Type 1 Diabetes Phase 2 Recruiting December 2018 United States, Colorado ... More >> University of Colorado-Denver, Anshutz Medical Campus Recruiting Aurora, Colorado, United States, 80045 Contact: Ellen Lyon, MS    720-848-6690    ellen.lyon@ucdenver.edu    Contact: Amy Baumgartner, MS    720-777-5774    amy.baumgartner@childrenscolorado.org Less <<
NCT01129674 Schizophrenia Phase 2 Phase 3 Terminated(The decision to sto... More >>p the trial was based on efficacy results in the overall schizophrenia participant population.) Less << - -
NCT03429946 Hypoglycemia ... More >>Healthy Less << Phase 4 Recruiting December 31, 2018 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02115 Contact: Jeffery White          Principal Investigator: Roy Freeman, MD          Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Rebecca Easly, BA    617-525-7357    reasly@bwh.harvard.edu    Contact: Gillian Murray, BA    617-278-0305    gmurray6@bwh.harvard.edu    Principal Investigator: Gail K Adler, MD, PhD Less <<
NCT02567877 - Recruiting June 2019 United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Recruiting Aurora, Colorado, United States, 80045 Contact: Emma Hulseberg-Dwyer    720-848-5146    emma.hulseberg-dwyer@ucdenver.edu    Contact: Kelsi Deaver, MD    720-848-2560    kelsi.deaver@ucdenver.edu Less <<
NCT02758431 Hypogonadism Not Applicable Recruiting January 2021 United States, Colorado ... More >> University of Colorado CCTSI CTRC Recruiting Denver, Colorado, United States, 80045 Contact: Kerrie Moreau, PhD    303-724-1914    kerrie.moreau@ucdenver.edu Less <<
NCT00779792 Dermatitis, Contact ... More >> Dermatitis, Occupational Less << Phase 4 Unknown November 2008 Denmark ... More >> Department of Dermatology, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT02735408 Bandages Musc... More >>le Tonus Low Back Pain Less << Phase 1 Unknown September 2016 Spain ... More >> Universidad Europea Recruiting Madrid, Spain Contact: Mónica García, PT, MSc       monica.garcia@universidadeuropea.es    Universidad Europea Recruiting Madrid, Spain Contact: Móncia García, PT, MSc    620005953    monica.garcia@universidadeuropea.es Less <<
NCT01392287 Major Depressive Disorder Phase 1 Completed - United States, Massachusetts ... More >> McLean Hospital Belmont, Massachusetts, United States, 02478 Less <<
NCT01749566 HIV Phase 1 Completed - United States, Georgia ... More >> Grady Infectious Diseases Program Atlanta, Georgia, United States, 30303 Less <<
NCT00630552 Adenocarcinoma of the Pancreas... More >> Metastatic Pancreatic Cancer Pancreatic Cancer Less << Phase 1 Phase 2 Completed - -
NCT01291381 Allergic Rhinitis ... More >> Effects of Immunotherapy Less << Not Applicable Completed - China ... More >> the allergy clinic of Beijing TongRen Hospital Beijing, China, 100730 Less <<
NCT01346085 Type 1 Diabetes Phase 1 Phase 2 Completed - Italy ... More >> IRCCS San Raffaele Scientific Institute Milan, Italy, 20132 Switzerland Universitè de Geneve Geneve, Switzerland, 1211 Less <<
NCT01988883 Postural Tachycardia Syndrome Early Phase 1 Active, not recruiting June 2019 United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37211 Less <<
NCT01346085 - Completed - -
NCT02478775 Obesity Ferti... More >>lity Less << Not Applicable Recruiting June 2019 United States, Colorado ... More >> University of Colorado Clinical and Translational Research Center Recruiting Aurora, Colorado, United States, 80045 Contact: Chanel Mansfield, BBA    303-724-6501    chanel.mansfield@ucdenver.edu    Principal Investigator: Alex Polotsky, MD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.78mL

0.36mL

0.18mL

8.91mL

1.78mL

0.89mL

17.82mL

3.56mL

1.78mL

 

Historical Records

Categories